Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis

Publisher Website
Google Scholar
Abstract
Summary 51 hospitalised patients with acute purulent exacerbations of chronic bronchitis were treated for ten days with two daily 1 g doses of the orally absorbed pro-drug cefuroxime axetil. However, some patients were still infected withHaemophilus influenzae orBranhamella catarrhalis at follow-up, and sputum purulence remained. Clinical results were “excellent” or “good” in 60% of the evaluable patients one week after the end of the treatment. Mean peak serum concentrations averaged 12.8 mg/l with mean peak sputum concentrations of 1.8 mg/l. The MIC90 value forH. influenzae was 4 mg/l. Three patients discontinued cefuroxime because of unwanted gastrointestinal drug effects, and three because of insufficient improvement. These results do not suggest that this compound is indicated for such patients.